Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Tranylcypromine sulfate 10mg film coated tablets (Alvogen Inc)
Section 19A approved medicine
(Approval lapsed) Tranylcypromine sulfate 10mg film coated tablets (Alvogen Inc)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
PARNATE tranylcypromine (as sulphate) 10mg film coated tablet blister pack - ARTG 174086
Indication(s)
Tranylcypromine sulfate is indicated for the treatment of symptoms of depressive illness especially where treatment with other types of antidepressants has failed. It is not recommended for use in mild depressive states resulting from temporary situational difficulties.